Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Novo Nordisk's Cardiometabolic Pivot: A Subtle Threat to Eli Lilly?

" This strategic reframing suggests a deliberate pivot, aiming to leverage the proven cardiovascular benefits of semaglutide, the active ingredient in Ozempic and Wegovy. The company's focus is shifting towards cardiovascular prevention, a market estimated to be worth over $15 billion annually in prescriptions. …

Nitish Kishor | 10 June 2026

OpenAI Filed for IPO After a $122 Billion Raise at $852 Billion, Here's Everything You Need to Know Before Deciding to Buy

OpenAI's recent filing for an initial public offering (IPO), valuing the company at an eye-watering $852 billion, positions it as the second most valuable IPO ever, trailing only behind SpaceX. This valuation, however, raises eyebrows among analysts, especially given OpenAI’s revenue of just $3.7 …

Nitish Kishor | 10 June 2026

Palantir Is Building an AI Data Fortress, Here's the Government-Commercial Convergence That Makes Its 80x Valuation Defensible

Palantir Technologies Inc. (NYSE: PLTR) is not merely a software company; it is a data fortress that leverages artificial intelligence to create a significant competitive advantage. Its Artificial Intelligence Platform (AIP) enables both government and commercial entities to derive insights from vast datasets. Each …

Nitish Kishor | 10 June 2026

Inflation Is Still Threatening Your Retirement, Here's the 4-Asset Class Strategy That Actually Works

As inflation continues to loom large, threatening the financial security of over 77 million Baby Boomers and early Gen Xers, the stakes for retirement planning have never been higher. The core Personal Consumption Expenditures (PCE) index is currently above 2.5%, and predictions from Goldman …

Nitish Kishor | 10 June 2026

JPMorgan's AI Offensive: A New Era for Banking Productivity and Profitability

JPMorgan Chase (JPM) is making a significant stride into the future of financial services by deploying more sophisticated enterprise AI agents. This initiative, targeting areas such as equity research, credit risk analysis, legal document review, and customer service, signals a profound shift in how …

Nitish Kishor | 10 June 2026

Micron Is a Buy After the AI Selloff, Here's the HBM Scarcity Story That Makes MU the Most Asymmetric Large-Cap Chip Stock

High-bandwidth memory (HBM) is among the most critical components in the evolving landscape of artificial intelligence (AI) applications. Micron Technology stands out as the sole US-based manufacturer of HBM3E memory, which is essential for powering the latest AI infrastructures. While the semiconductor industry grapples …

Nitish Kishor | 10 June 2026

Nebius Is Falling Despite Being an AI Cloud Pioneer, Here's the Hyperscaler Crowding-Out Effect That's Killing Independent AI Infrastructure

The rapid expansion of artificial intelligence (AI) technology has led to unprecedented investments in cloud infrastructure by major hyperscalers. Companies like Amazon Web Services (AWS), Microsoft Azure, and Google Cloud are each committing more than $100 billion annually to bolster their AI capabilities. This …

Nitish Kishor | 10 June 2026

NextEra and Dominion's Deal Is the Biggest Utility Partnership in a Decade, Here's the Clean Energy Economics Behind the Restructuring

The recent partnership between NextEra Energy and Dominion Energy is a significant development in the utility sector, creating the largest utility partnership in a decade. This deal aims to combine the strengths of both companies, with NextEra providing its expertise in solar, battery storage, …

Nitish Kishor | 10 June 2026

Corporate America Just Swapped $500 Billion in Buybacks for AI Capex, Here's What This Seismic Shift Means for Every Stock You Own

In a transformative move, S&P 500 companies are redirecting an estimated $400-500 billion annually from stock buybacks to artificial intelligence capital expenditures. This decision heralds the most significant corporate capital allocation change since the post-World War II industrial boom. The transition reflects a burgeoning …

Nitish Kishor | 10 June 2026

CVS Health Is the Turnaround Opportunity of 2026, Here's the Specific Execution Plan That Could Double the Stock in 3 Years

CVS Health, a major player in the healthcare industry, is undergoing a significant transformation. The company has announced a three-part turnaround plan aimed at driving growth and improving profitability. This plan involves exiting unprofitable health insurance market segments, monetising its retail pharmacy locations, and …

Nitish Kishor | 10 June 2026
Support

Hi! How can we help you today?

Loading…